MedTrace Logo

Trans Health: Evaluation of Markers of Cardio-metabolic Health and Well-being in Transgender Youth

NCT02550431 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2018-02-05

No results posted yet for this study

Summary

This study plans to learn more about puberty blockers and cross (testosterone and estradiol). There is not much known about how these medications affect hormone levels, heart health and overall general health in young transgender individuals.

Conditions

  • Transgendered Persons

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Natalie J Nokoff, MD · University of Colorado, Denver

Eligibility

Min Age
9 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2018-01-26
Completion
2018-01-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02550431 on ClinicalTrials.gov